In addition, cardiac glycoside ouabain, a Na/K-ATPase inhibitor, induces Bcl-2 reduction due to JNK1 activation, which disrupts Bcl-2/Beclin-1 interaction and results in caspase-independent autophagic cell death in NSCLC cells [38]. Here, MAPK8 is linked to non-small cell lung carcinoma.